Trastuzumab (Herceptin®) trials in adjuvant breast cancer. CT =... | Download Scientific Diagram
Herceptin side effects: What they are and how to manage them
HERCEPTIN Dosage & Rx Info | Uses, Side Effects
Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer | SpringerLink
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡ - Annals of Oncology
Long-Term Side Effects of Cancer Treatment | Cancer.Net
Herceptin® Improves Cancer-Free Survival in HER2 + positive Early Breast Cancer - CancerConnect
Cancers | Free Full-Text | Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma | HTML
PPT - What's New in HER2: Current Issues in HER2 Positive Breast Cancer PowerPoint Presentation - ID:1849950
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
Herceptin: A Wonder Drug With a Frightening Side Effect
Long-Term Data Show The Impact of Herceptin On Treating HER2-Positive Breast Cancer
What Can I Expect? Late Effects of Breast Cancer Treatment - Komen Perspectives - Susan G. Komen®
Metastatic Breast Cancer IV Infusion | PERJETA® (pertuzumab)
A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin | Journal of the American Chemical Society
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab - ScienceDirect
Breast Cancer Treatment: Herceptin Shorter Duration
Trastuzumab and Cardiotoxicity | IntechOpen
Targeted therapeutic options and future perspectives for HER2-positive breast cancer | Signal Transduction and Targeted Therapy
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab - ScienceDirect
Trastuzumab treatment in patients with breast cancer and metastatic CNS disease - Annals of Oncology
Heart Issues That Are a Herceptin Side Effect Can Be Reduced | Everyday Health
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model | Scientific Reports
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer - The Breast
The mechanistic insights of the arrhythmogenic effect of trastuzumab - ScienceDirect
